Riverbridge Partners LLC Lowers Holdings in Oak Street Health, Inc. (NYSE:OSH)

Riverbridge Partners LLC decreased its stake in Oak Street Health, Inc. (NYSE:OSHGet Rating) by 0.1% during the second quarter, Holdings Channel reports. The institutional investor owned 2,798,861 shares of the company’s stock after selling 1,707 shares during the quarter. Riverbridge Partners LLC’s holdings in Oak Street Health were worth $46,013,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. Benjamin Edwards Inc. boosted its stake in shares of Oak Street Health by 9,016.7% in the first quarter. Benjamin Edwards Inc. now owns 1,094 shares of the company’s stock worth $29,000 after buying an additional 1,082 shares during the last quarter. Fifth Third Bancorp purchased a new stake in shares of Oak Street Health in the first quarter worth about $46,000. Gleason Group Inc. purchased a new stake in shares of Oak Street Health in the first quarter worth about $54,000. Captrust Financial Advisors boosted its stake in shares of Oak Street Health by 114.5% in the first quarter. Captrust Financial Advisors now owns 2,688 shares of the company’s stock worth $72,000 after buying an additional 1,435 shares during the last quarter. Finally, Hardy Reed LLC purchased a new stake in shares of Oak Street Health in the first quarter worth about $79,000. Hedge funds and other institutional investors own 91.33% of the company’s stock.

Insider Activity at Oak Street Health

In related news, Director Newlight Partners Lp sold 7,000,000 shares of the stock in a transaction that occurred on Friday, August 19th. The stock was sold at an average price of $24.72, for a total value of $173,040,000.00. Following the completion of the sale, the director now owns 33,509,640 shares of the company’s stock, valued at $828,358,300.80. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, insider Geoffrey M. Price sold 96,568 shares of the stock in a transaction that occurred on Tuesday, June 28th. The stock was sold at an average price of $18.56, for a total value of $1,792,302.08. Following the completion of the transaction, the insider now directly owns 1,796,702 shares in the company, valued at $33,346,789.12. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Newlight Partners Lp sold 7,000,000 shares of the stock in a transaction that occurred on Friday, August 19th. The stock was sold at an average price of $24.72, for a total value of $173,040,000.00. Following the completion of the transaction, the director now owns 33,509,640 shares of the company’s stock, valued at $828,358,300.80. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 9,087,019 shares of company stock valued at $227,581,646. 11.40% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on OSH shares. Morgan Stanley upped their price target on Oak Street Health from $19.00 to $30.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 31st. Evercore ISI upped their price target on Oak Street Health to $37.00 in a report on Tuesday, August 9th. Cowen upped their price target on Oak Street Health to $34.00 in a report on Tuesday, August 9th. Argus started coverage on Oak Street Health in a report on Tuesday, July 26th. They issued a “hold” rating for the company. Finally, Stifel Nicolaus upped their price target on Oak Street Health from $25.00 to $35.00 in a report on Wednesday, July 27th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $32.75.

Oak Street Health Stock Performance

NYSE:OSH opened at $28.46 on Monday. Oak Street Health, Inc. has a one year low of $13.29 and a one year high of $54.14. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 16.10. The stock has a 50 day moving average price of $27.02 and a 200 day moving average price of $22.86.

Oak Street Health (NYSE:OSHGet Rating) last posted its quarterly earnings results on Tuesday, August 2nd. The company reported ($0.66) EPS for the quarter, missing the consensus estimate of ($0.49) by ($0.17). Oak Street Health had a negative net margin of 27.11% and a negative return on equity of 1,883.59%. The company had revenue of $523.70 million during the quarter, compared to analyst estimates of $520.62 million. On average, analysts forecast that Oak Street Health, Inc. will post -2.44 EPS for the current year.

Oak Street Health Company Profile

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

Recommended Stories

Want to see what other hedge funds are holding OSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oak Street Health, Inc. (NYSE:OSHGet Rating).

Institutional Ownership by Quarter for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.